Intrathecal drug delivery systems for the management of chronic non-cancer pain: Protocol for a systematic review of economic evaluations

BMJ Open

Volumn 6, Issue 7, 2016, Pages

  Duarte, Rui V ^a   Lambe, Tosin ^a   Raphael, Jon H ^b,c   Eldabe, Sam ^d   Andronis, Lazaros ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM CITY UNIVERSITY   (United Kingdom)

^c RUSSELLS HALL HOSPITAL   (United Kingdom)

^d JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

ARTICLE; CANCER PAIN; CHECKLIST; CHRONIC NON CANCER PAIN; CHRONIC PAIN; CLINICAL EVALUATION; COCHRANE LIBRARY; COST EFFECTIVENESS ANALYSIS; DRUG DELIVERY SYSTEM; ECONOMIC EVALUATION; EMBASE; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HUMAN; MANAGED CARE; MEDLINE; QUALITY CONTROL; SYSTEMATIC REVIEW; WEB OF SCIENCE; COST BENEFIT ANALYSIS; ECONOMICS; ENGLAND; INTRASPINAL DRUG ADMINISTRATION; META ANALYSIS (TOPIC); NATIONAL HEALTH SERVICE; PROCEDURES;

CHRONIC PAIN; COST-BENEFIT ANALYSIS; DRUG DELIVERY SYSTEMS; ENGLAND; HUMANS; INJECTIONS, SPINAL; META-ANALYSIS AS TOPIC; STATE MEDICINE;

EID: 84991407497     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-012285     Document Type: Article

References (41)

1. Loeser JD, Arendt-Nielsen L, Baron R, et al. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms/prepared by the International Association for the Study of Pain, Task Force on Taxonomy. 2nd rev edn. Seattle: IASP Press, 2012.
2. Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287-333.
3. Macfarlane GJ, Beasley M, Smith BH, et al. Can large surveys conducted on highly selected populations provide valid information on the epidemiology of common health conditions? An analysis of UK Biobank data on musculoskeletal pain. Br J Pain 2015;9:203-12.
4. Bridges S. Chapter 9: chronic pain. In: Craig R, Mindell J, eds. Health survey for England 2011, health, social care and lifestyles. London: The Health and Social Care Information Centre, 2012:1-33.
5. Moody A. Chapter 4: diabetes and hyperglycaemia. In: Craig R, Mindell J, eds. Health survey for England 2011, health, social care and lifestyles. London: The Health and Social Care Information Centre, 2012:1-28.
6. Donaldson L. Pain: breaking through the barrier. In: Donaldson L, ed. 150 years of the annual report of the chief medical officer: on the state of public health 2008. London: Department of Health, 2009:32-9.
7. Price C, Hoggart B, Olukoga O, et al. National Pain Audit Final Report 2012-2012. London: Healthcare Quality Improvement Partnership, British Pain Society and Dr Foster Intelligence, 2012.
8. Hoy D, March L, Brooks P, et al. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis 2014;73:968-74.
9. Phillips CJ. The cost and burden of chronic pain. Rev Pain 2009;3:2-5.
10. Krames ES, Olson K. Clinical realities and economic considerations: patient selection in intrathecal therapy. J Pain Symptom Manage 1997;14:S3-13.
11. Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010: CD006605.
12. Duarte RV, Raphael JH, Sparkes E, et al. Long-term intrathecal drug administration for chronic nonmalignant pain. J Neurosurg Anesthesiol 2012;24:63-70.
13. Sparkes E, Duarte RV, Mann S, et al. Analysis of psychological characteristics impacting spinal cord stimulation treatment outcomes: a prospective assessment. Pain Physician 2015;18:E369-77.
14. Mann SA, Sparkes E, Duarte RV, et al. Attrition with spinal cord stimulation. Br J Neurosurg 2015;29:823-8.
15. May A. Chronic pain may change the structure of the brain. Pain 2008;137:7-15.
16. Rodriguez-Raecke R, Niemeier A, Ihle K, et al. Brain gray matter decrease in chronic pain is the consequence and not the cause of pain. J Neurosci 2009;29:13746-50.
17. Kumar K, Hunter G, Demeria D. Spinal cord stimulation in treatment of chronic benign pain: challenges in treatment planning and present status, a 22-year experience. Neurosurgery 2006;58:481-96.
18. Onofrio BM, Yaksh TL, Arnold PG. Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc 1981;56:516-20.
19. Coombs DW, Saunders RL, Gaylor MS, et al. Relief of continuous chronic pain by intraspinal narcotics infusion via an implanted reservoir. JAMA 1983;250:2336-9.
20. Lamer TJ. Treatment of cancer-related pain: when orally administered medications fail. Mayo Clin Proc 1994;69:473-80.
21. Nordberg G, Hedner T, Mellstrand T, et al. Pharmacokinetic aspects of intrathecal morphine analgesia. Anesthesiology 1984;60:448-54.
22. Prager JP. Neuraxial medication delivery: the development and maturity of a concept for treating chronic pain of spinal origin. Spine 2002;27:2593-605.
23. Deer T, Winkelmüller W, Erdine S, et al. Intrathecal therapy for cancer and nonmalignant pain: patient selection and patient management. Neuromodulation 1999;2:55-66.
24. Deer TR, Prager J, Levy R, et al. Polyanalgesic Consensus Conference-2012: recommendations on trialing for intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation 2012;15:420-35; discussion 435.
25. Deer TR, Hayek S, Pope J, et al. The Polyanalgesic Consensus Conference (PACC) guidelines for intrathecal drug delivery infusion system trialing. Neuromodulation 2016. In press.
26. Duarte R, Raphael J, Eldabe S. Intrathecal drug delivery for the management of pain and spasticity in adults: an executive summary of the British Pain Society's recommendations for best clinical practice. Br J Pain 2016;10:67-9.
27. Eldabe S, Duarte R, Raphael J, et al. Intrathecal drug delivery for the management of pain and spasticity in adults; recommendations for best clinical practice. London: British Pain Society, 2015.
28. Smith TJ, Staats PS, Deer T, et al. Implantable Drug Delivery Systems Study Group. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002;20:4040-9.
29. Narendran RC, Duarte RV, Valyi A, et al. The need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database. BMJ Open 2015;5:e007517.
30. Raphael JH, Duarte RV, Southall JL, et al. Randomised, double-blind controlled trial by dose reduction of implanted intrathecal morphine delivery in chronic non-cancer pain. BMJ Open 2013;3:e003061.
31. NHS England. Clinical commissioning policy: intrathecal pumps for treatment of severe cancer pain. 2015. https://www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2015/10/d08pb-intra-pumps-trtmnt.pdf (accessed 10 Dec. 2015).
32. NHS Commissioning Board. Clinical commissioning policy: intrathecal baclofen (ITB). 2013. https://www.england.nhs.uk/wp-content/uploads/2013/04/d04-p-c.pdf (accessed 10 Dec. 2015).
33. NHS England. Clinical commissioning policy: intrathecal pumps for treatment of severe chronic pain. 2015. https://www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2015/10/d08pa-intrathecal-pumps-oct15.pdf (accessed 10 Dec. 2015).
34. Shamseer L, Moher D, Clarke M, et al, PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015;349:g7647.
35. Centre for Reviews and Dissemination. Search strategies. 2015. http://www.crd.york.ac.uk/crdweb/searchstrategies.asp (accessed 17 Dec. 2015).
36. Scottish Intercollegiate Guidelines Network. Search filters. 2015. http://www.sign. ac.uk/methodology/filters.html (accessed 17 Dec. 2015).
37. Drummond MF, Sculpher MJ, Torrance GW. Methods for the economic evaluation of health care programmes. 3rd edn. Oxford: Oxford University Press, 2005.
38. Evers S, Goossens M, de Vet H, et al. Criteria list for assessment of methodological quality of economic evaluations: consensus on health economic criteria. Int J Technol Assess Health Care 2005;21:240-5.
39. Philips Z, Ginnelly L, Sculpher M, et al. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess 2004;8:iii-iv, ix-xi, 1-158.
40. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. [updated March 2011]. Chichester: John Wiley & Sons, 2011.
41. Shemilt I, Mugford M, Byford S, et al., on behalf of the Campbell and Cochrane Economics Methods Group. Chapter 15: incorporating economics evidence. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. Chichester: John Wiley & Sons, 2011. http://handbook.cochrane.org/chapter-15/15-10-chapter-information. htm